Date | Price Target | Rating | Analyst |
---|---|---|---|
1/3/2024 | $32.00 | Overweight | Barclays |
12/6/2023 | Mkt Perform | JMP Securities |
10-Q - HEALTHSTREAM INC (0001095565) (Filer)
8-K - HEALTHSTREAM INC (0001095565) (Filer)
8-K - HEALTHSTREAM INC (0001095565) (Filer)
4 - HEALTHSTREAM INC (0001095565) (Issuer)
4 - HEALTHSTREAM INC (0001095565) (Issuer)
4 - HEALTHSTREAM INC (0001095565) (Issuer)
HealthStream, Inc. (the "Company") (NASDAQ:HSTM), a leading healthcare technology platform for workforce solutions, announced today results for the second quarter ended June 30, 2024. Second Quarter 2024 Revenues of $71.6 million in the second quarter of 2024, up 3.4% from $69.2 million in the second quarter of 2023 Operating income of $4.4 million in the second quarter of 2024, up 10.1% from $4.0 million in the second quarter of 2023 Net income of $4.2 million in the second quarter of 2024, up 0.8% from $4.1 million in the second quarter of 2023 Earnings per share (EPS) of $0.14 per share (diluted) in the second quarter of 2024, up from $0.13 per share (diluted) in the second
HealthStream, Inc. (NASDAQ:HSTM), a leading healthcare technology platform for workforce solutions, announced today that it will hold a conference call and webcast to discuss its second quarter 2024 financial results on Tuesday, July 23rd, 2024. The Company's financial results for the second quarter ended June 30th, 2024 will be released after the routine time for the close of the market on Monday, July 22nd, 2024. HealthStream's second quarter 2024 earnings conference call will begin at 9:00 a.m. Eastern Time on Tuesday, July 23rd, 2024. Participants may access the conference call live via webcast using this link: Webcast Link Here. To participate via telephone, please register in advanc
HealthStream, Inc. (the "Company") (NASDAQ:HSTM), a leading healthcare technology platform for workforce solutions, announced today results for the first quarter ended March 31, 2024. First Quarter 2024 Revenues of $72.8 million in the first quarter of 2024, up 6% from $68.9 million in the first quarter of 2023 Operating income of $5.7 million in the first quarter of 2024, up 97% from $2.9 million in the first quarter of 2023 Net income of $5.2 million in the first quarter of 2024, up 99% from $2.6 million in the first quarter of 2023 Earnings per share (EPS) of $0.17 per share (diluted) in the first quarter of 2024, up from $0.09 per share (diluted) in the first quarter of 20
SC 13G/A - HEALTHSTREAM INC (0001095565) (Subject)
SC 13G - HEALTHSTREAM INC (0001095565) (Subject)
SC 13G/A - HEALTHSTREAM INC (0001095565) (Subject)
Canaccord Genuity analyst Richard Close maintains HealthStream (NASDAQ:HSTM) with a Hold and raises the price target from $27 to $28.
HealthStream (NASDAQ:HSTM) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.12 by 33.33 percent. The company reported quarterly sales of $71.556 million which missed the analyst consensus estimate of $72.851 million by 1.78 percent. This is a 3.41 percent increase over sales of $69.198 million the same period last year.
Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results. Nucor reported quarterly earnings of $3.46 per share which missed the analyst consensus estimate of $3.65. Quarterly sales came in at $8.14 billion, missing the analyst consensus estimate of $8.26 billion, according to data from Benzinga Pro. Nucor shares tumbled 6.5% to $179.20 on Tuesday. Here are some other stocks moving in today’s mid-day session. Gainers Cyngn Inc. (NASDAQ:CYN) shares jumped 100% to $0.2419 after the company announced that it has been chosen to supply its DriveMod Tuggers for industrial automation to Joh
HealthStream, Inc. (the "Company") (NASDAQ:HSTM), a leading healthcare technology platform for workforce solutions, announced today results for the second quarter ended June 30, 2024. Second Quarter 2024 Revenues of $71.6 million in the second quarter of 2024, up 3.4% from $69.2 million in the second quarter of 2023 Operating income of $4.4 million in the second quarter of 2024, up 10.1% from $4.0 million in the second quarter of 2023 Net income of $4.2 million in the second quarter of 2024, up 0.8% from $4.1 million in the second quarter of 2023 Earnings per share (EPS) of $0.14 per share (diluted) in the second quarter of 2024, up from $0.13 per share (diluted) in the second
HealthStream, Inc. (NASDAQ:HSTM), a leading healthcare technology platform for workforce solutions, announced today that it will hold a conference call and webcast to discuss its second quarter 2024 financial results on Tuesday, July 23rd, 2024. The Company's financial results for the second quarter ended June 30th, 2024 will be released after the routine time for the close of the market on Monday, July 22nd, 2024. HealthStream's second quarter 2024 earnings conference call will begin at 9:00 a.m. Eastern Time on Tuesday, July 23rd, 2024. Participants may access the conference call live via webcast using this link: Webcast Link Here. To participate via telephone, please register in advanc
HealthStream, Inc. (the "Company") (NASDAQ:HSTM), a leading healthcare technology platform for workforce solutions, announced today results for the first quarter ended March 31, 2024. First Quarter 2024 Revenues of $72.8 million in the first quarter of 2024, up 6% from $68.9 million in the first quarter of 2023 Operating income of $5.7 million in the first quarter of 2024, up 97% from $2.9 million in the first quarter of 2023 Net income of $5.2 million in the first quarter of 2024, up 99% from $2.6 million in the first quarter of 2023 Earnings per share (EPS) of $0.17 per share (diluted) in the first quarter of 2024, up from $0.09 per share (diluted) in the first quarter of 20
Barclays initiated coverage of HealthStream with a rating of Overweight and set a new price target of $32.00
JMP Securities initiated coverage of HealthStream with a rating of Mkt Perform
Canaccord Genuity reiterated coverage of HealthStream with a rating of Hold and set a new price target of $24.00 from $22.00 previously